查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945292

2026年全球基因檢測市場報告

Hereditary Genetic Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基因檢測市場發展迅速，預計將從2025年的238.8億美元成長到2026年的265.6億美元，複合年成長率達11.2%。這一成長歸因於多種因素，例如遺傳疾病盛行率的上升、分子診斷在臨床上的應用日益廣泛、診斷檢查室的擴張、人們對遺傳疾病認知的提高以及基礎基因檢測技術的廣泛應用。

預計未來幾年基因檢測市場將快速成長，到2030年市場規模將達到401.2億美元，複合年成長率（CAGR）為10.9%。預測期內的成長要素包括：次世代定序技術的進步、個人化醫療需求的成長、藥物基因組學應用的拓展、預防性醫療醫療費用支出的增加以及基因諮詢服務的普及。預測期內的主要趨勢包括：預防性和預測性基因檢測的普及率不斷提高、對早期癌症風險評估的需求不斷成長、面向消費者的基因檢測服務日益成長、產前和新生兒基因篩檢的擴展以及人們對遺傳性心血管疾病和罕見疾病的認知不斷提高。

癌症發生率的不斷上升將進一步推動未來基因檢測市場的擴張。癌症是一組以細胞不受控制地生長為特徵的疾病，並有可能侵入或轉移到身體的其他部位。癌症發生率的上升受多種因素影響，例如年齡成長、生活方式改變、環境暴露、遺傳易感性以及診斷技術的進步。基因檢測有助於識別與癌症風險增加相關的遺傳基因突變，從而實現早期監測和預防策略。例如，根據英國麥克米倫癌症援助組織（Macmillan Cancer Support）統計，截至2024年8月，英國有超過300萬人患有癌症，預計到2025年這一數字將增至350萬，到2030年將增至400萬，到2040年將增至530萬。因此，日益加重的癌症負擔正在推動基因檢測市場的擴張。

基因檢測市場的主要企業正致力於開發先進的基因組解決方案，例如多癌多基因檢測，以支援早期檢測和個人化治療策略。多癌多基因檢測可同時分析多個基因，識別與不同癌症相關的突變，從而支持風險評估和個人化治療。例如，總部位於美國的癌症篩檢和診斷檢測服務提供者Exact Sciences於2024年2月推出了Riskguard遺傳性癌症檢測。該檢測使用血液或唾液樣本，可提供基因特異性和遺傳性癌症風險的個人化訊息，從而支持知情的篩檢決策、治療計劃和家族風險評估。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球基因檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 擴大預防性和預測性基因檢測的應用
    • 對早期癌症風險評估的需求日益成長
    • 直接面對消費者的基因檢測服務的成長
    • 擴大產前和新生兒基因篩檢
    • 提高對遺傳性心血管疾病和罕見疾病的認知

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 研究所
  • 直接面對消費者的基因檢測公司（DTC）
  • 遺傳諮詢中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球基因檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球基因檢測市場規模、對比及成長率分析
  • 全球基因檢測市場表現：規模與成長，2020-2025年
  • 全球基因檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 預測性/無症狀檢測、基因帶原檢測、產前/新生兒檢測、診斷性檢測、藥物基因體學檢測及其他類型
  • 透過技術
  • 細胞遺傳學、生物化學和分子檢測
  • 透過臨床應用
  • 癌症基因檢測、心血管基因檢測、神經系統基因檢測、罕見疾病基因檢測
  • 最終用戶
  • 醫院/診所、診斷實驗室、研究實驗室、直接面對消費者（DTC）的基因檢測公司
  • 按類型細分：預測性測試和臨床前測試
  • 基因檢測用於疾病風險預測、遺傳性癌症風險檢測、心血管疾病風險檢測、神經退化性疾病風險檢測
  • 按類型細分：基因帶原檢測
  • 遺傳疾病檢測、體染色體隱性遺傳疾病基因篩檢、遺傳疾病帶因者狀態檢測
  • 按類型細分：產前和新生兒檢測
  • 非侵入性產前檢測（NIPT）、羊膜穿刺術及絨毛膜取樣（CVS）、新生兒篩檢、孕前基因篩檢
  • 按類型細分：診斷測試
  • 基因檢測用於確診疑似遺傳疾病、檢測遺傳症候群和先天性疾病、診斷癌症和腫瘤譜分析。
  • 按類型細分：藥物基因組學檢測
  • 藥物反應和療效的基因檢測、藥物敏感性和副作用檢測、個人化醫療和治療最佳化
  • 按類型細分：其他類型
  • 用於健康促進和生活方式的基因檢測、用於祖源和家族史研究的基因檢測、用於研究目的的基因檢測

第10章 區域與國家分析

  • 全球基因檢測市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球基因檢測市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 基因檢測市場：競爭格局及市場佔有率（2024年）
  • 基因檢測市場：公司估值矩陣
  • 基因檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Eurofins Scientific SE

第37章：其他領先和創新企業

  • Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix SLP, Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年基因檢測市場：提供新機會的國家
  • 2030年基因檢測市場：蘊藏新機會的細分領域
  • 2030年基因檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MHGTE01_G26Q1

Hereditary genetic testing analyzes DNA to detect inherited gene mutations that may increase the risk of disease. It helps identify genetic conditions that may be passed from parents to children, including cancers, heart diseases, and rare inherited disorders.

The primary types of hereditary genetic testing include predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others. Predictive and presymptomatic testing helps identify individuals with a genetic likelihood of developing specific diseases before clinical symptoms appear. The technologies used include cytogenetic testing, biochemical testing, and molecular testing. Clinical applications include cancer genetic testing, cardiovascular genetic testing, neurological genetic testing, and rare disease genetic testing. The end users consist of hospitals and clinics, diagnostic laboratories, research institutes, and direct-to-consumer (DTC) genetic testing providers.

Tariffs are impacting the hereditary genetic testing market by increasing costs for imported laboratory instruments, reagents, and sequencing equipment, impacting overall testing affordability. Molecular testing and pharmacogenomic testing segments are most affected, particularly in regions such as Asia-Pacific and Latin America that rely heavily on imported diagnostic technologies. These cost pressures have slowed adoption in price-sensitive markets. However, tariffs have also encouraged domestic manufacturing of testing kits and reagents, fostering local innovation and strengthening regional diagnostic capabilities.

The hereditary genetic testing market research report is one of a series of new reports from The Business Research Company that provides hereditary genetic testing market statistics, including hereditary genetic testing industry global market size, regional shares, competitors with a hereditary genetic testing market share, detailed hereditary genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary genetic testing industry. This hereditary genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary genetic testing market size has grown rapidly in recent years. It will grow from $23.88 billion in 2025 to $26.56 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of hereditary disorders, growing clinical adoption of molecular diagnostics, expansion of diagnostic laboratories, rising awareness of genetic diseases, availability of basic genetic testing technologies.

The hereditary genetic testing market size is expected to see rapid growth in the next few years. It will grow to $40.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to advancements in next-generation sequencing technologies, growing demand for personalized medicine, expansion of pharmacogenomic applications, increasing healthcare spending on preventive care, wider integration of genetic counseling services. Major trends in the forecast period include rising adoption of preventive and predictive genetic testing, increasing demand for early cancer risk assessment, growth of direct-to-consumer genetic testing services, expansion of prenatal and newborn genetic screening, rising awareness of inherited cardiovascular and rare diseases.

The increasing prevalence of cancer is increasingly supporting the expansion of the hereditary genetic testing market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth with the potential to invade or spread to other parts of the body. The growing prevalence of cancer is influenced by aging populations, lifestyle changes, environmental exposures, genetic predispositions, and improved diagnostic capabilities. Hereditary genetic testing helps identify inherited genetic mutations linked to increased cancer risk, enabling early surveillance and preventive strategies. For example, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with projections indicating growth to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the increasing cancer burden is contributing to the expansion of the hereditary genetic testing market.

Leading companies operating in the hereditary genetic testing market are focusing on developing advanced genomic solutions, such as multi-cancer multigene panels, to support early detection and personalized treatment strategies. Multi-cancer multigene panels analyze multiple genes simultaneously to identify mutations linked to different cancers, aiding risk assessment and tailored care. For example, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, launched the Riskguard hereditary cancer test. This test delivers personalized insights into gene-specific and familial cancer risks using a blood or saliva sample, supporting informed screening decisions, treatment planning, and family risk evaluation.

In August 2024, Laboratory Corporation of America Holdings (Labcorp), a US-based laboratory services company, acquired selected assets of Invitae Corporation for an undisclosed amount. With this acquisition, Labcorp aims to expand its specialty testing capabilities and strengthen its use of genetic data to improve clinical trials and treatment approaches in oncology and select rare diseases. Invitae Corporation is a US-based provider of medical genetics services, including genetic testing solutions for oncology and rare diseases.

Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC, Centogene N.V., CooperSurgical Inc., Sema4

North America was the largest region in the hereditary genetic testing market in 2025 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hereditary genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hereditary genetic testing market includes revenues earned by entities by providing services such as carrier screening, prenatal testing, and newborn screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Genetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hereditary genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Predictive And Presymptomatic Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing; Other Types
  • 2) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing
  • 3) By Clinical Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Rare Diseases Genetic Testing
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Direct To Consumer (DTC) Genetic Testing Companies
  • Subsegments:
  • 1) By Predictive And Presymptomatic Testing: Genetic Testing For Disease Risk Prediction; Testing For Inherited Cancer Risks; Cardiovascular Disease Risk Testing; Neurodegenerative Disease Risk Testing
  • 2) By Carrier Testing: Testing For Inherited Genetic Disorders; Genetic Screening For Autosomal Recessive Diseases; Testing For Carrier Status Of Inherited Conditions
  • 3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis and Chorionic Villus Sampling (CVS); Newborn Screening For Genetic Disorders; Preconception Genetic Screening
  • 4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders; Testing For Inherited Syndromes And Congenital Diseases; Diagnostic Testing For Cancer And Tumor Profiling
  • 5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy; Testing For Drug Sensitivities And Side Effects; Personalized Medicine And Treatment Optimization
  • 6) By Other Types: Genetic Testing For Wellness And Lifestyle; Genetic Testing For Ancestry And Genealogy; Research-Oriented Genetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Hologic Inc.; Exact Sciences Corporation; Fulgent Genetics Inc.; BioReference Laboratories Inc.; BGI Group; Invitae Corporation; Color Health Inc.; MedGenome Inc.; Devyser AB; Mapmygenome India Ltd.; Igenomix S.L.P.; Myriad Genetics Inc.; Natera Inc.; Ambry Genetics Corporation; GeneDx LLC; Centogene N.V.; CooperSurgical Inc.; Sema4
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hereditary Genetic Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hereditary Genetic Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hereditary Genetic Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hereditary Genetic Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Preventive And Predictive Genetic Testing
    • 4.2.2 Increasing Demand For Early Cancer Risk Assessment
    • 4.2.3 Growth Of Direct-To-Consumer Genetic Testing Services
    • 4.2.4 Expansion Of Prenatal And Newborn Genetic Screening
    • 4.2.5 Rising Awareness Of Inherited Cardiovascular And Rare Diseases

5. Hereditary Genetic Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Direct To Consumer (Dtc) Genetic Testing Companies
  • 5.5 Genetic Counseling Centers

6. Hereditary Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hereditary Genetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hereditary Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hereditary Genetic Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hereditary Genetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hereditary Genetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hereditary Genetic Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hereditary Genetic Testing Market Segmentation

  • 9.1. Global Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
  • 9.2. Global Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cytogenetic Testing, Biochemical Testing, Molecular Testing
  • 9.3. Global Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
  • 9.4. Global Hereditary Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies
  • 9.5. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Predictive And Presymptomatic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
  • 9.6. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
  • 9.7. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Prenatal and Newborn Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
  • 9.8. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes And Congenital Diseases, Diagnostic Testing For Cancer And Tumor Profiling
  • 9.9. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities And Side Effects, Personalized Medicine And Treatment Optimization
  • 9.10. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing

10. Hereditary Genetic Testing Market Regional And Country Analysis

  • 10.1. Global Hereditary Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hereditary Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hereditary Genetic Testing Market

  • 11.1. Asia-Pacific Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hereditary Genetic Testing Market

  • 12.1. China Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hereditary Genetic Testing Market

  • 13.1. India Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hereditary Genetic Testing Market

  • 14.1. Japan Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hereditary Genetic Testing Market

  • 15.1. Australia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hereditary Genetic Testing Market

  • 16.1. Indonesia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hereditary Genetic Testing Market

  • 17.1. South Korea Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hereditary Genetic Testing Market

  • 18.1. Taiwan Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hereditary Genetic Testing Market

  • 19.1. South East Asia Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hereditary Genetic Testing Market

  • 20.1. Western Europe Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hereditary Genetic Testing Market

  • 21.1. UK Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hereditary Genetic Testing Market

  • 22.1. Germany Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hereditary Genetic Testing Market

  • 23.1. France Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hereditary Genetic Testing Market

  • 24.1. Italy Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hereditary Genetic Testing Market

  • 25.1. Spain Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hereditary Genetic Testing Market

  • 26.1. Eastern Europe Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hereditary Genetic Testing Market

  • 27.1. Russia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hereditary Genetic Testing Market

  • 28.1. North America Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hereditary Genetic Testing Market

  • 29.1. USA Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hereditary Genetic Testing Market

  • 30.1. Canada Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hereditary Genetic Testing Market

  • 31.1. South America Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hereditary Genetic Testing Market

  • 32.1. Brazil Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hereditary Genetic Testing Market

  • 33.1. Middle East Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hereditary Genetic Testing Market

  • 34.1. Africa Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hereditary Genetic Testing Market Regulatory and Investment Landscape

36. Hereditary Genetic Testing Market Competitive Landscape And Company Profiles

  • 36.1. Hereditary Genetic Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hereditary Genetic Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hereditary Genetic Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Hereditary Genetic Testing Market Other Major And Innovative Companies

  • Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC

38. Global Hereditary Genetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hereditary Genetic Testing Market

40. Hereditary Genetic Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Hereditary Genetic Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hereditary Genetic Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hereditary Genetic Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer